By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tacere Therapeutics, Inc. 

5941 Optical Court

San Jose  California  95138  U.S.A.
Phone: 408-960-2205 Fax: 408-960-2207



Start Up

Company News
Benitec, Inc. (BLT.AX) Announces Acquisition of Tacere Therapeutics, Inc. and Phase I/II Ready Hepatitis C (HCV) Program 10/11/2012 9:00:27 AM
Tacere Therapeutics, Inc. Reacquires Rights to Develop and Commercialize its Hepatitis C Compounds in Asia from Oncolys BioPharma 2/4/2011 7:59:03 AM
Exiqon A/S Announces Achievement of Primary Milestones in RNAi Project for Tacere Therapeutics, Inc. 9/15/2009 8:46:43 AM
Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer Inc. (PFE) To Develop and Commercialize RNAi Hepatitis C Drug 1/7/2008 8:46:39 AM
Oncolys BioPharma and Tacere Therapeutics Form Strategic Alliance to Develop RNAi Hepatitis C Drug 6/21/2007 11:24:00 AM
Tacere Therapeutics Appoints Vice President, Research And Development 11/14/2006 12:29:13 PM
Tacere Therapeutics Secures Financing And Resumes Development Of RNAi Hepatitis C Drug 10/12/2006 11:25:42 AM